Immunosenescence and cancer
- PMID: 20656212
- DOI: 10.1016/j.critrevonc.2010.06.012
Immunosenescence and cancer
Abstract
Age is a major risk factor for many cancers. Although this is usually viewed in the context of the cell biology, we argue here that age-associated changes to immunity may also contribute to the age-associated increasing incidence of most cancers. This is because cancers are immunogenic (at least initially), and the immune system can and does protect against tumourigenesis. However, immune competence tends to decrease with age, a phenomenon loosely termed "immunosenescence", implying that decreased immunosurveillance against cancer could also contribute to increased disease in the elderly. This review weighs some of the evidence for and against this possibility.
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Immunosenescence and cancer.Biogerontology. 2017 Aug;18(4):717-721. doi: 10.1007/s10522-017-9682-z. Epub 2017 Feb 20. Biogerontology. 2017. PMID: 28220304 Review.
-
Potential role of immunosenescence in cancer development.Ann N Y Acad Sci. 2010 Jun;1197:158-65. doi: 10.1111/j.1749-6632.2009.05370.x. Ann N Y Acad Sci. 2010. PMID: 20536845 Review.
-
Aging, immunity, and cancer.Discov Med. 2011 Jun;11(61):537-50. Discov Med. 2011. PMID: 21712020 Review.
-
Can exercise-related improvements in immunity influence cancer prevention and prognosis in the elderly?Maturitas. 2013 Sep;76(1):51-6. doi: 10.1016/j.maturitas.2013.06.010. Epub 2013 Jul 17. Maturitas. 2013. PMID: 23870832 Review.
-
The role of immunity in elderly cancer.Crit Rev Oncol Hematol. 2010 Apr;74(1):40-60. doi: 10.1016/j.critrevonc.2009.06.002. Epub 2009 Jul 4. Crit Rev Oncol Hematol. 2010. PMID: 19577481 Review.
Cited by
-
Immune Checkpoint Inhibitors in Older Adults.Curr Oncol Rep. 2016 Aug;18(8):47. doi: 10.1007/s11912-016-0534-9. Curr Oncol Rep. 2016. PMID: 27287329 Review.
-
Reversing the immune ageing clock: lifestyle modifications and pharmacological interventions.Biogerontology. 2018 Dec;19(6):481-496. doi: 10.1007/s10522-018-9771-7. Epub 2018 Sep 29. Biogerontology. 2018. PMID: 30269199 Free PMC article. Review.
-
Integrative analysis of aging-related genes reveals CEBPA as a novel therapeutic target in non-small cell lung cancer.Cancer Cell Int. 2024 Jul 27;24(1):267. doi: 10.1186/s12935-024-03457-4. Cancer Cell Int. 2024. PMID: 39068458 Free PMC article.
-
Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach.Ther Clin Risk Manag. 2021 Jun 30;17:669-677. doi: 10.2147/TCRM.S308194. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34234443 Free PMC article.
-
Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients.Jpn J Clin Oncol. 2024 Jul 7;54(7):827-832. doi: 10.1093/jjco/hyae046. Jpn J Clin Oncol. 2024. PMID: 38651176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical